| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Collaboration revenue | ||||||
20,789 | 15,753 | |||||
Operating expenses: | ||||||
Research and development, net | ||||||
33,640 | 16,982 | |||||
General and administrative | ||||||
12,662 | 20,582 | |||||
Total operating expenses | ||||||
46,302 | 37,564 | |||||
Loss from operations | ||||||
-25,513 | -21,811 | |||||
Loss from equity-method investment | ||||||
-32 | -302 | |||||
Finance expense, net | ||||||
-446 | 328 | |||||
Net loss | ||||||
-25,991 | -21,785 | |||||
Net loss per share, basic and diluted | ||||||
-2.15 | -2.16 | |||||
Weighted-average shares outstanding, basic and diluted | ||||||
12,069 | 10,069 | |||||
Comprehensive loss: | ||||||
Net loss | ||||||
-25,991 | -21,785 | |||||
Unrealized gain on short-term investments | ||||||
- | 3 | |||||
Comprehensive loss | ||||||
-25,991 | -21,782 | |||||